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Abstract
Background: Trinucleotide instability is a hallmark of degenerative neurological diseases like 
Huntington's disease, some forms of spinocerebellar ataxia and myotonic dystrophy type l (DM l). 
To investigate the effect of cell type and cell state on the behavior of the DMl CTG*CAG repeat, 
we studied a knock-in mouse model for DMl at different time points during ageing and followed 
how repeat fate in cells from liver and pancreas is associated with polyploidization and changes in 
nuclearity after the onset of terminal differentiation.
Results: After separation of liver hepatocytes and pancreatic acinar cells in pools with 2n, 4n or 
8n DNA, we analyzed CTG*CAG repeat length variation by resolving PCR products on an 
automated PAGE system. We observed that somatic CTG*CAG repeat expansion in our DMl 
mouse model occurred almost uniquely in the fraction of cells with high cell nuclearity and DNA 
ploidy and aggravated with aging.
Conclusion: Our findings suggest that post-replicative and terminal-differentiation events, 
coupled to changes in cellular DNA content, form a preconditional state that influences the control 
of DNA repair or recombination events involved in trinucleotide expansion in liver hepatocytes 
and pancreatic acinar cells.
Background
Instability of CTG*CAG trinucleotide repeats forms an 
im portant class of mutations on an ever-growing list of 
inheritable degenerative neurological diseases, including 
Huntington's disease, several spinocerebellar ataxias 
(SCAs 1, 2, 3, 6, 7, 8, 12 and 17) and myotonic dystrophy 
type 1 (DM1) [1-3]. Depending on disease type, patho­
genic mechanisms may vary, but all disorders have in 
common that the transition to illness appears to be a cell-
intrinsic process, which is initiated by intergenerational or 
somatic repeat expansion or both. Although substantial 
progress has been made by the study of expansion behav­
ior and associated pathophysiological events in  repeat- 
containing bacterial and yeast model systems [4], transla­
tion of findings to the mammalian system is not easy and 
there is still disagreement over the contribution to 
CTG*CAG repeat expansion by new strand synthesis dur­
ing DNA replication or DNA repair and recombination in
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cycling or quiescent cells for the various diseases. Also 
effects of cell-type and cell-state during development, 
adulthood and aging are generally not well understood. 
Yet, exactly this knowledge is needed to aid in the devel­
opm ent of therapeutic modalities.
Since the discovery of its molecular defect, DM1 has been 
an archetypal case within the group of unstable trinucle­
otide diseases. In DM1 both progenitor CTG*CAG repeat 
length and somatic expansion determine age of onset and 
severity of disease, which is characterized by muscular 
dystrophy and myotonia in  combination with a highly 
variable manifestation of features like cataract, heart con­
duction defects, insulin insensitivity and cognitive impair­
ment. The DM1 m utation is an expansion of a CTG*CAG 
repeat in the 3' UTR of the DMPK gene on chromosome 
19. Once DM1 alleles are in the disease-associated size 
range (>50 CTG*CAG repeats), repeat tracts become dra­
matically unstable. Intergenerational m utation rates may 
be almost 100% per generation, with a tendency towards 
further repeat gains [5-7]. The DM1 repeat is also somati­
cally unstable and extensive instability in  a wide range of 
hum an tissues is what makes DM1 a truly unique trinucle­
otide disorder [5,8,9].
Somatic expansion is mediated by multiple small length 
changes in  a highly deterministic process which is clearly 
age-dependent, with longer average DM1 repeat length 
and broader ranges of variability observed in  older 
patients [7,9]. We know that somatic expansions accumu­
late in  both proliferating and post-mitotic tissues, suggest­
ing that expansion is independent of cell division [8,10]. 
Furthermore, the rate of instability of the CTG*CAG 
repeat in  DM1 is correlated to repeat length and is proba­
bly due to an increased ability of the repeat sequence to 
form aberrant DNA structures, such as slipped strand 
structures with out-of-register alignment of the comple­
mentary strands, cruciforms or intramolecular triplex and 
quadruplex structures with single-stranded regions [4]. 
Failure in  the processing of these structures, a cascade of 
reactions in which mismatch repair proteins -  e.g., MSH2, 
MSH3, PMS2 or MLH1 -  likely play a role, may underlie 
mutagenic instability [11-14]. Aberrant DNA break repair 
induced by these structures may also be at the basis of 
instability [15]. In addition, as-acting factors such as 
nearby replication origins or CpG islands may influence 
instability [3,16].
We here report on an analysis towards the role of cell type 
and cell stage in CTG*CAG instability in different tissues 
of a mouse knock-in DM1 model, where a hum an 
(CTG*CAG)n repeat segment (n ~ 110) replaces the cog­
nate 3' segment of the endogenous mouse Dmpk gene 
[13]. We concentrated on tissues that continuously divide
and tissues with non-cycling cells that undergo terminal 
maturation early in  life or during aging.
Results
Our group has developed a knock-in mouse model in 
which somatic expansion of the DM1 CTG*CAG tract is 
faithfully reproduced. In this animal model a short seg­
ment of hum an chromosomal DNA spanning the exon 
13-15 region of the DMPK gene of a DM1 patient with an 
abnormal (CTG*CAG)84 repeat replaces the exact cognate 
segment of the endogenous mouse Dmpk gene. Hence, 
this places chromatin embedding of the repeat element 
and production of repeat containing DMPK mRNA under 
"natural" host control. Study of this model revealed that 
the mutability of the repeat is age-dependent and activity 
of the mismatch repair protein Msh3 (usually found asso­
ciated in the Msh2/Msh3 MutSP repair complex) is impor­
tant for repeat expansion, whereas the Msh6 protein 
(found in association with Msh2 in the MutSa complex) 
appears dispensable [13].
In this model, we now analyzed the cell-type and cell- 
stage dependence of CTG*CAG instability in different tis­
sues in  more detail. Analysis of PCR-amplified DMPK 
repeat segments originating from tissues with a moderate 
to low fraction of cycling cells like skin, bone marrow or 
heart showed a typical Gaussian distribution of allele 
sizes, slowly expanding to greater average length during 
aging (Fig. 1A). In contrast, tissues with a rather high 
repeat expansion rate, like kidney and stomach, displayed 
a significant broadening of the profile (see data presented 
in [13]), while liver and pancreas displayed a typical 
bimodal distribution profile (Fig. 1BC). Typically, after 
about six months of age the fraction of cells with no or 
moderately expanded alleles remained constant, but alle­
les in  the already expanded pool of cells continued to 
increase in  length. As the bimodal profile in  liver and pan­
creas became increasingly pronounced with age, we con­
sidered effects of terminal differentiation and aging the 
best explanation for this phenomenon, rather than cell- 
type differences or tissue heterogeneity. Polyploidization, 
which is the state of acquiring a greater than diploid con­
tent of DNA, is one of few distinct events that mark phys­
iologically normal late differentiation and is a 
distinguishing feature of liver hepatocytes and pancreatic 
acinar cells [17-19]. We therefore decided to concentrate 
on these cell types and analyze whether changes in  cell 
nuclearity, hyperploidy or G2 state -  or any state where 
two identical chromosome copies of the expanded 
CTG*CAG tract would coexist in one cell -  could selec­
tively affect repeat hypermutability via effects on hom ol­
ogy-directed DNA recombination or repair.
Hepatocytes constitute approximately 60-70%  of liver 
cells and up to 90% of liver mass [17,18]. We employed a
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Figure!
Effects of aging on the somatic CTG*CAG repeat length distribution in heart, liver and pancreas. Typical 
CTG*CAG length profiles of genomic DNA isolated from heart (A), liver (B) or pancreas (C) of a knock-in mouse model car­
rying a humanized DMPK gene with a (CTG*CAG)n repeat [13]. Arrows indicate the position of the progenitor allele deter­
mined from analysis of tail DNA at time of weaning. Note the slow but uniform broadening of the profile with slight shift 
towards greater repeat lengths upon aging in heart, in contrast to the bimodal repeat length distribution in liver and pancreas.
two-step collagenase perfusion protocol to disperse liver 
into single hepatocytes and non-parenchymal cells [20] 
(see Methods). Single hepatocytes were isolated and FACS 
fractionation was employed to sort the cell suspension in 
pools of 2n (diploid, mononuclear), 4n or 8n cells (both 
populations contained mononuclear and binuclear cells; 
collectively called polyploid) (Table 1; Fig. 2A,C inset). By 
analyzing the length distribution of PCR products from 
the repeat area on PAGE gels, and comparing peak areas 
in typical profiles as shown in Fig. 2C, we estimate that 
over 95% of hepatocytes in the 4 and the 8n cell pools 
harbored large expanded repeat alleles, whereas the 
majority of cells in the diploid cell pool carried repeats 
with progenitor allele size or only marginal length expan­
sions (Fig. 2C). Comparison of different animals showed 
that less than 15-20% of the cells in  the diploid pool har­
bored expansions and the percentage of expanded cells 
seemed to drop further with age. The typical overrepresen­
tation of m utant alleles in the 4n and 8n cell pools was 
already apparent around six months of age when the poly- 
ploidization process had stopped, but the average repeat 
size increased further during aging (Table 1, and see data 
in [13]). As a cautionary note, we would like to stress here 
that the procedures used for liberation of single dispersed 
cells from tissue and the ploidy-sorting will not yield 
absolutely pure populations as cell aggregation and shear­
ing cannot be avoided completely, and also cell cycle state 
(i.e., G0 or G2 phase) may affect the sorting efficiency.
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Yet, it is striking that expansion fate in the >4n pools 
always appeared much more homogeneous than that in 
the 2n pools, where 10-20% of cells appeared expanded. 
Importantly, the time course of genesis of 4n and 8n liver 
cells, and hence the postnatal development and mainte­
nance of the polyploidization profile in our CTG*CAG 
knock-in lineage occurred as in wild type mice and was 
essentially completed within the first four months of life. 
Approximately 50% of all liver cells became tetraploid- 
octaploid, with a 20% versus 80% ratio between mono- 
and binuclearity (Table 1, data not shown). We thus may 
assume that the end-stage of differentiation in liver of our 
model is reached via a physiologically normal and step­
wise process, with creation of binuclear cells preceding the 
formation of mononuclear tetraploid cells, as has been 
described in detail for rat liver [17].
To study whether bi-allelic presence of expanded 
CTG*CAG repeats could further alter repeat mutability in 
liver -  and vice versa, whether repeat dosage would affect 
liver cell polyploidization -  we also intercrossed animals 
of our CTG*CAG knock-in lineage and followed repeat 
fate during aging of homozygous animals with 
(CTG*CAG)104/(CTG*CAG)112 or (CTG*CAG)105/ 
(CTG*CAG)110 alleles. No effects of compound homozy­
gosity were observed and repeat size profiles developed 
similarly in 2n, 4n or 8n hepatocyte pools from monoal- 
lelic (CTG*CAG)110 and compound homozygous (bi- 
allelic mutant) (CTG*CAG)104/(CTG*CAG)112 or 
(CTG*CAG)105/(CTG*CAG)110 mice during aging (Fig. 3). 
Also ploidy development occurred as in heterozygous or 
wild type animals.
Finally, to examine whether the apparent association 
between trinucleotide repeat expansion ability and poly- 
ploidization was more general in  nature and occurred in 
other cell types as well, we monitored repeat m utation fre­
quency also in pancreatic cells. In Figure 2B we show gel 
mobility analyses on PCR products from 2n and 4n pan­
creatic acinar cells collected after FACS analysis. Virtually 
all cells (>99%) in these preparations had retained typical 
acinar cell attributes including zymogen granules (Fig. 
2D, inset). Notably, again a very high proportion of 2n 
cells (estimated fraction >90%) yielded signals in the orig­
inal CTG*CAG size range, whereas alleles in the 4n acinar 
cells almost all were of higher length (Fig. 2D; less than 
5% of 4n acinar cells contained alleles in the 
(CTG*CAG)108 range).
Discussion and conclusion
In conclusion, although our data are of associative nature, 
our observations strongly suggest that polyploidization is 
not a condition that is directly involved in  the expansion 
process per se, bu t merely establishes a cell state that must 
be reached before repeat expansion can be promoted later 
in life. If this cell state -  considered the end-state of differ­
entiation -  is reached gradually and late in life of diploid 
cells, the ability to expand may even become manifest 
before the actual transition to multinuclearity or poly­
ploidy. This would explain why a small proportion (10­
15%) of 2n hepatocytes harbour expanded alleles and 
that this proportion appears higher in  early adulthood 
than at very old age. In mouse liver, already after few 
months of age a new end-state of differentiation is 
reached, and the fraction of multinucleate or polyploid 
cells does not increase further. Repeat expansion appears 
to continue over the entire life span of the animal, how­
ever (results shown in Table 1 and ref. [13]). When taken 
together, these observations link expansion most tightly 
to the post-replicative state, as polyploid cells in  liver and 
pancreas are non-cycling [17-19]. Expansion appears also 
transcription independent, as the Dmpk gene is expressed 
at very low levels in  hepatocytes and appears fully 
repressed in acinar cells [[21], own findings, unpub­
lished] . Also other cell types that show polyploidization, 
like arterial smooth muscle cells, cardiomyocytes and 
Purkinje cells are generally non-cycling and it will there­
fore become important to study repeat fate also in  these 
cells. Unfortunately, there are no good experimental pro­
tocols available for their isolation, cultivation, and sepa­
ration into 2n or >4n cell pools, so this remains work to 
be done for the future.
Interestingly, reciprocal correlations exist between the cell 
state and its DNA recombination-repair capacity that may 
affect repeat stability. Checkpoint degeneracy with an 
interesting change in  the survey role of p53 has been 
observed after transition to tetraploidy [22]. We have
Table 1: C o rre lation  between age, som atic expansion, ploidy and nuclearity in DM1 knock-in m ice
Age* 1 - 3 months 12 - 25 months
Somatic Expansion no yes
Ploidy 2n 4n 8n 2n 4n 8n
54 ± 9% 45 ± 8% 2 ± 2% 45 ± 5% 43 ± 3% 13 ± 3%
Nuclearity 100% 80% binuclear n.d. 100% 80% binuclear 80% binuclear
mononuclear mononuclear
* n = 5 for 1-3 months-old mice and n = 8 for 12-25 months-old mice; n.d., not determined
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Figure 2
Polyploid cells in liver and pancreas display enhanced somatic instability of the CTG*CAG repeat. (A, B) Liver 
hepatocytes from a 17-month-old mouse and pancreatic acinar cells from a 21-month-old mouse were isolated, fixed, stained 
with propidium iodide and FACS purified based on DNA content. Preparative sorting profiles based on PI fluorescence inten­
sity are shown. All 2n hepatocytes were mononuclear, whereas ~80% cells in the 4n and 8n pools of hepatocytes were binu­
clear (C, inset; typical examples of cells in the sorted 2n and 4n cell pools stained with Giemsa, are shown). Note that pancreas 
contained only diploid and tetraploid cells (a fluorescent PAS staining of zymogen inclusions established the identity of acinar 
cells (D, inset)). (C, D) CTG*CAG length profiles of hepatocytes and acinar cells demonstrated much larger average repeat 
length and almost complete absence of progenitor alleles in cells with 4n DNA (red; liver hepatocytes and acinar cells) and 8n 
DNA (black; liver hepatocytes only). In the 2n pools obtained from liver and pancreas (blue) only a small percentage of cells 
contained expanded repeats. Arrows indicate the position of the progenitor allele determined from analysis of tail DNA at 
time of weaning.
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Figure3
Somatic instability of CTG*CAG repeats in liver 
hepatocytes of mice containing two humanized 
DMPK alleles (compound homozygotes). Hepatocytes 
were isolated from a 14-month-old compound homozygous 
(CTG*CAG)|04/(CTG*CAG) | |2 and a 16-month-old 
(CTG*CTG)|05/(CTG*CAG)||0 mouse and sorted in 2n and 
4n cells. PCR profiles of genomic DNA show that in both 
mice the average CTG*CAG repeat length in the pool of 4n 
cells (red) is much larger than in the 2n cell pool (blue) and 
shifted to larger length for both progenitor alleles. Arrows 
indicate the positions of the two progenitor (CTG*CAG)n 
alleles in tail DNA at time of weaning.
observed changes in the level of DNA recombination- 
repair protein RPA, which parallel the process of terminal 
differentiation and aging of liver (data not shown). A defi­
ciency of DNA repair protein ERCC1 in mice results in 
accelerated polyploidization rates in liver [23]. Vice versa, 
polyploidization and associated changes in either cell 
size, or the process of aging itself [24], may alter cellular 
metabolism, thereby contributing to changes in the 
genetic stability of terminally differentiated cells. Meta­
bolic effects on the activities of MLH1 and MutSa, compo­
nents of the mismatch repair machinery that determine 
trinucleotide repeat stability, have been reported [25,26] 
and activity of DNA repair proteins, like Ku, is modulated
during aging in liver [27]. Based on these observations 
and our findings reported here, additional investigations 
are warranted to understand how changes in both cell 
nuclearity and DNA ploidy correlate to altered efficacy of 
the machinery that controls somatic CTG*CAG repeat sta­
bility in DM1.
Methods
Isolation o f  liver hepatocytes
Hepatocytes were isolated using a two-step collagenase 
liver perfusion protocol [20]. After administration of 
anesthesia and heparin, perfusion was performed via the 
left ventricle with 30 ml Hepes buffer (25 mM Hepes, pH
7.5, 0.25 mM EGTA), followed by 10 ml Hepes buffer 
without EGTA, and finally 25 ml Hepes buffer containing
2 mM CaCl2 and 0.025% (w/v) collagenase IV (Sigma). 
After isolation of the liver and disrupting Glisson's cap­
sule, cells were gently pushed out and filtered through a 
70 |im filter (Falcon). Three washes with medium (1 x 
DMEM, 15% FCS, 4 mM glutamine/1 mM pyruvate, 50 
|ig/ml gentamycin) in combination with low speed cen­
trifugation at 500 rpm for five m in were done for hepato- 
cyte enrichment. In our hands, this procedure yielded 
highly (>95% enriched, but never 100% pure) hepatocyte 
populations.
Isolation o f  pancrea tic  acinar ce lls
Mouse pancreatic acinar cells were isolated as described 
[28,29] with some modifications. Cells were collected 
after a two-step digestion with Hepes buffer (140 mM 
NaCl, 5.4 mM KCl, 0.8 mM Na2HPO4, 25 mM Hepes, 5.8 
mM glucose, pH 7.5) including 0.1 mM CaCl2, 1 mM 
MgCl2 and 0.05% collagenase IV (Sigma). After filtration 
through a 70 |im  nylon gauze (Falcon), cells were purified 
through a 4% (w/v) BSA layer in Hepes buffer with 1 mM 
CaCl2 and 1 mM MgCl2 by low speed centrifugation (5 
min, 500 rpm). Cells were resuspended in Hepes buffer 
with 1% (w/v) BSA, 1 mM CaCl2 and 1 mM MgCl2, where­
after the last step was repeated.
FACS analysis
Single cells were fixed in 70% (v/v) ethanol overnight at - 
20°C. After a PBS wash, cells were resuspended in PBS 
containing 20 |ig/ml propidium iodide, 0.2 mg/ml RNase 
and 0.1% Triton X-100, followed by a 15 m in incubation 
at 37°C. Cells were excited at 488 nm  and emission was 
measured at 610 nm  using a Beckman Coulter Epics Elite 
ESP. Diploid, tetraploid and octaploid cells were sorted 
and isolated. The average number of polyploid hepato­
cytes in our adult mice ranged between ~50-70% and 
remained stable after five m onths of age [17,18].
PAS staining
To control for purity of our cell population, isolated pan­
creatic acinar cells were attached on superfrost plus slides
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and fixed in 4% phosphate-buffered formol (pH 7). Slides 
were stained for 5 m in in periodic acid solution and for 15 
m in in Schiff solution [30]. Autofluorescence from PAS- 
positive structures was recorded using a Zeiss Axioplan 2 
microscope. Typical preparations obtained, were esti­
mated >99% pure.
C T G C A G  repea t length analysis
DNA was isolated after proteinase K treatment, phenol/ 
chloroform extraction and isopropanol precipitation. 
DNA concentrations in different samples were equili­
brated in accordance with the number and ploidy of cells 
used in the sorted population(s) and PCR was performed 
with forward primer 226 (5'-GAAGGGTCCTTGTAGCCG- 
GGAA-3') and Cy5-labeled reverse primer 225 (5'-GGAG- 
GATGGAACACGGACGG-3') flanking the CTG*CAG 
tract. PCR products were analyzed on a 6% denaturing 
acrylamide-urea gel in the ALF DNA sequencing (Amer- 
sham Pharmacia) system. PCR products obtained from 
amplification of Each (CTG*CAG)n repeat length profile 
was normalized to its highest peak to be able to optimally 
compare the relative contribution of fragments with 
expanded repeats between different profiles.
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